The impact of type 2 diabetes duration on serum asymmetric dimethylarginine and C-reactive protein concentration in Bosnian patients Cover

.blurhash-client-img { display: none !important; }

The impact of type 2 diabetes duration on serum asymmetric dimethylarginine and C-reactive protein concentration in Bosnian patients

Endocrine Regulations

Volume 56 (2022): Issue 4 (October 2022)

By: Asija Zaciragic, Amela Dervisevic, Nesina Avdagic, Nermina Babic, Amina Valjevac, Orhan Lepara and Jasminko Huskic

Open Access

|Oct 2022

DOI: https://doi.org/10.2478/enr-2022-0029 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 271 - 278

Published on: Oct 20, 2022

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

asymmetric dimethylarginine,

C-reactive protein,

endothelial dysfunction,

systemic low-grade inflammation,

type 2 diabetes mellitus

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2022 Asija Zaciragic, Amela Dervisevic, Nesina Avdagic, Nermina Babic, Amina Valjevac, Orhan Lepara, Jasminko Huskic, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2022): Issue 4 (October 2022)Next article